Concepedia

Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)

Leslie M. Randall, David M. O’Malley, Bradley J. Monk, Robert L. Coleman, Stéphanie Gaillard, Sarah F. Adams, Linda Duska, Heather Dalton, Robert W. Holloway, Marilyn Huang,

Gynecologic Oncology · 2023 · 26 citations · 29 references

DOIFull text

Open access

Concepts

References

29

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

, , +14

Cancer Statistics, 2021

Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2021 · 17.4K citations · Full text

, , +16

Ovarian cancer statistics, 2018

Lindsey A. Torre, Britton Trabert, Carol DeSantis et al. · CA A Cancer Journal for Clinicians · 2018 · 3.7K citations · Full text

, , +16

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

, , +17

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt et al. · New England Journal of Medicine · 2016 · 2.5K citations · Full text

, , +15